EUROLyser Diagnostica - Premium Laboratory Equipment

beta-Hydroxybutyrate: A new diabetes monitoring assay for cats

Tuesday, 29. April 2025

EUROLyser presents its next new parameter for the measurement of beta-Hydroxybutyrate. This test provides reliable, precise and immediate results for veterinarians.

The Parameter

beta-Hydroxybutyrate (BHB) is one of three main ketone bodies that the liver produces to provide energy to muscles and other tissues when glucose levels are low. In diabetic individuals, those ketone bodies can build up in the bloodstream and lead to diabetic ketoacidosis – a life-threatening condition, if untreated.

Not only is BHB produced at a higher rate than the other main ketone bodies, but also predominantly at the onset of diabetic ketoacidosis, making it a reliable early phase detection marker.

Your advantages

  • Easy test procedure
  • Results in < 10 minutes
  • In-house analysis
  • Decisive results

Method

Enzymatic determination with beta-Hydroxybutyrate-dehydrogenase.

Measurement range

0.08 – 10 mmol/l

 

For more information, please visit the beta Hydroxybutyrate Test page.

EUROLyser News

29. April 2025

beta-Hydroxybutyrate: A new diabetes monitoring assay for cats...
» Read more...

18. August 2020

SDMA: A new veterinary assay for evaluation of chronic kidney diseases...
» Read more...

17. August 2020

Phenobarbital: A next generation epilepsy monitoring assay...
» Read more...

10. December 2019

Launch of bidirectional connectivity: a feature for CUBE series instruments...
» Read more...